• TPG Buying Par Pharmaceutical Companies, Inc. (PRX) for About $1.84 Billion More...

• Thermo Fisher Scientific (TMO) Agrees to Buy One Lambda, Inc. for $925 Million Cash More...

• Seattle Genetics, Inc. (SGEN) CEO Not Interested in a Sale More...

• New Johnson & Johnson (JNJ) CEO to Discuss $20 Billion Purchase in 2Q Report More..

• FDA Spied on Its Own Scientists More...


• Raleigh Startup, Sprout Pharmaceuticals Raises $20 Million in Search of "Female Viagra" More...

• Coferon, Inc. Announces $12 Million Series B Financing More...

• Juventas Therapeutics, Inc. Raises $22.2 Million Series B Financing More...


• Novavax, Inc. (NVAX), CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India More...

• NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, and SOTIO Enter Into a Phase 3 Manufacturing Services Agreement More...

• MedPro Safety Products, Inc. (MPSP.OB) Signs Letter of Intent With Specialty Pharmaceutical Company More...

• Retrophin, LLC and St. Jude Children's Research Hospital to Collaborate on Rare Disease Research Program More...

• RegeneRx Biopharmaceuticals, Inc. (RGRX) and Lee's Pharmaceutical (HK) Limited Complete License Agreement for Development of RegeneRxProduct Candidates in China (including Hong Kong and Macau) and Taiwan More...


• AstraZeneca PLC (AZN)'s Ex-CEO Forfeits 2012 Bonus More...

• Pacific Biosciences Appoints Jonas Korlach, Ph.D. Chief Scientific Officer More...

• BIND Biosciences, Inc. Appoints Andrew J. Hirsch as Chief Financial Officer More...

• Opko Health, Inc. Announces Appointment of Juan F. Rodriguez as Chief Financial Officer More...

• Timothy A. Ryan, PhD Joins Galenea's Scientific Advisory Board More...


• Celgene Corporation (CELG) to Announce Second Quarter 2012 Results on July 26, 2012 More...

• FEI Company Announces Dates for Earnings Release and Investor Conference Participation More...

• Momenta Pharmaceuticals, Inc. (MNTA) Announces Date of Second Quarter 2012 Financial Results Conference Call More...

• Obagi Medical Products, Inc. (OMPI) to Report Second Quarter 2012 Financial Results and Host a Conference Call on August 2 More...

• FDA OKs Gilead Sciences, Inc. (GILD)'s Truvada for HIV Prev. More...

• Baxter International, Inc. (BAX) Announces FDA Approval of ADVATE 4000 IU Dosage Strength More...

• Hospira, Inc. (HSP) Recalls 4 Cancer Drugs More...

• Zogenix, Inc. Announces FDA Acceptance for Review of Zohydro ER™ New Drug Application (NDA) for Treatment of Chronic Pain More...

• Anthera Pharmaceuticals, Inc. (ANTH) Provides Additional Data From the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population More...

• Cellceutix (CTIX) Meets Manufacturers to Synthesize Psoriasis Drug Candidate for Clinical Trials; Site Initiation Visit for Clinical Trials of Kevetrin to Happen this Week More...

• Pharming Group (PHGUF.PK) Confirms Safety Profile of Recombinant Human Lactoferrin in a Food Safety Study in Healthy Human Volunteers More...

• Peregrine Pharmaceuticals, Inc. (PPHM) Announces Initiation of a Phase I Rectal Adenocarcinoma Investigator-Sponsored Trial More...

• Medpace, Inc. Completes Construction on a New Clinical Pharmacology Unit -- Expanding Phase I-IIA Clinical Research Capabilities More...

• Chemicals in Cosmetics May Spike Diabetes Risk, Brigham and Women's Hospital Study More...

• Slower Walking Speed a Sign of Dementia, Mayo Clinic Study More...

• Want to Lose Weight? Keep a Food Journal, Don't Skip Meals and Avoid Going Out to Lunch, Fred Hutchinson Cancer Research Center Study More...

• Walking, Resistance Training May Improve Memory, University of Pittsburgh Study More...

• Orgenesis Chief Science Officer Describes Science in Two Online Publications More...